ZA914675B - 5-isothiazolamine derivatives - Google Patents

5-isothiazolamine derivatives

Info

Publication number
ZA914675B
ZA914675B ZA914675A ZA914675A ZA914675B ZA 914675 B ZA914675 B ZA 914675B ZA 914675 A ZA914675 A ZA 914675A ZA 914675 A ZA914675 A ZA 914675A ZA 914675 B ZA914675 B ZA 914675B
Authority
ZA
South Africa
Prior art keywords
isothiazolamine
derivatives
isothiazolamine derivatives
Prior art date
Application number
ZA914675A
Other languages
English (en)
Inventor
Thijs De Boer
De Boer Thijs
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA914675B publication Critical patent/ZA914675B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA914675A 1990-07-03 1991-06-18 5-isothiazolamine derivatives ZA914675B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90307246 1990-07-03

Publications (1)

Publication Number Publication Date
ZA914675B true ZA914675B (en) 1992-04-29

Family

ID=8205476

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914675A ZA914675B (en) 1990-07-03 1991-06-18 5-isothiazolamine derivatives

Country Status (11)

Country Link
US (1) US5179110A (xx)
EP (1) EP0464946A1 (xx)
JP (1) JPH04230379A (xx)
KR (1) KR920002594A (xx)
AU (1) AU641513B2 (xx)
CA (1) CA2045003A1 (xx)
FI (1) FI913173A (xx)
IE (1) IE911994A1 (xx)
NZ (1) NZ238796A (xx)
PT (1) PT98184A (xx)
ZA (1) ZA914675B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
KR101209343B1 (ko) * 2005-10-07 2012-12-06 엘지전자 주식회사 샘플링속도조절기능의 터치패널장치 및 그 제어방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) * 1988-12-28 1991-09-03 Roussel Maestretti S P A Ora R Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali

Also Published As

Publication number Publication date
FI913173A0 (fi) 1991-06-28
US5179110A (en) 1993-01-12
FI913173A (fi) 1992-01-04
IE911994A1 (en) 1992-01-15
KR920002594A (ko) 1992-02-28
EP0464946A1 (en) 1992-01-08
PT98184A (pt) 1992-05-29
JPH04230379A (ja) 1992-08-19
AU641513B2 (en) 1993-09-23
NZ238796A (en) 1992-12-23
AU7949691A (en) 1992-02-27
CA2045003A1 (en) 1992-01-04

Similar Documents

Publication Publication Date Title
EP0440950A3 (en) Halogenallyl-azolyl derivatives
HU912356D0 (en) Rapacmycine derivatives
ZA916098B (en) Oxazolidinodione derivatives
EP0470466A3 (en) Halogenalkyl-azolyl derivatives
GR3023621T3 (en) 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives
ZA914484B (en) Azolyl-propanol derivatives
IL96819A0 (en) Azaoxindole derivatives
HRP930485A2 (en) Hiv-inhibiting benzenacetamide derivatives
IL99576A0 (en) Triazacyclohexane derivatives
EP0438690A3 (en) Substituted pyrazolin derivatives
ZA916254B (en) Halogenoalkyl-azolyl derivatives
EP0485984A3 (en) Diarylmethoxypiperidine derivatives
ZA914204B (en) Pyridinylpiperazine derivatives
OA09670A (en) Carbo-nucleoside derivatives
EP0440949A3 (en) Halogenallyl-azolyl derivatives
ZA914675B (en) 5-isothiazolamine derivatives
EP0453883A3 (en) 2-amino-4-trichloropyridine derivatives
AP9100308A0 (en) Carboxymethylcyclopropane derivatives
GB2249094B (en) Hetero-imidazodiazepine derivatives
GB9006772D0 (en) 4-piperidinyl-ergoline derivatives
EG19474A (en) Nitroenamine derivatives
EG19362A (en) Azoaxindole derivatives
HU9202568D0 (en) 3-piperidino-4-hydroxi-chromane derivatives
ZA914804B (en) Antimigrine alkoxypyrimidine derivatives
NZ240842A (en) 4-phenoxy- and 4-pyridoxy-benzaldehyde derivatives